Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
View the latest research on other companies in the sector.
VICORE PHARMA - BUY | SEK60 Please Join Our Virtual KOL Call to Discuss IPF: 12th October, 11-12 pm EST/5-6 pm CEST KOL call details
VICORE PHARMA HOLDING Vicore Pharma Holding AB
This event is intended for institutional clients of Bryan Garnier (BG) only. If you are a client of Bryan Garnier, please register via the link.
VICORE PHARMA | BUY | SEK60 No biggie, Phase 3 COVID19 data release is a clearing event for IPF update in Q4 • -> COVID19 Phase 3 ATTRACT trial is a clearing event • -> We maintain a BUY rating with SEK60 TP, COVID was not in our model
Share: